Patents by Inventor Lynne Connor

Lynne Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070243270
    Abstract: Methods of reducing cellular damage are described that include (a) administering to the mammal an oral dosage form comprising a therapeutically effective amount of a first antioxidant, and (b) administering to the mammal a topical dosage form comprising a therapeutically effective amount of a second antioxidant, wherein at least one of the first antioxidant and the second antioxidant comprises acerola concentrate. Methods of inhibiting free radical production, methods of scavenging free radicals, and kits for reducing cellular damage are also described.
    Type: Application
    Filed: January 18, 2007
    Publication date: October 18, 2007
    Inventors: Gregory Evans, Gregory Grochoski, Russell Randolph, Lynne Connor, John Scimeca, Kevin Gellenbeck, James Mayne, Haeri Roh-Schmidt, Thomas Slaga, Margareth Hanausek-Walaszek, Zbigniew Walaszek
  • Publication number: 20060198810
    Abstract: The present invention relates to formulations of ingredients that are useful for improving the appearance, texture and/or moisture of skin. In particular, the formulations of the present invention stimulate collagen, elastin, and lipid synthesis and/or inhibit or minimize the loss of collagen, elastin, and lipids in the skin. Additionally, the formulations of the present invention inhibit matrix metalloproteases, such as MMP-1, MMP-9, collagenase, or elastase.
    Type: Application
    Filed: March 7, 2005
    Publication date: September 7, 2006
    Inventors: Mary Murray, Aaron Crawford, David Fast, Dora Dong, Michael Huang, Lynne Connor
  • Publication number: 20050100537
    Abstract: Methods of reducing cellular damage are described that include (a) administering to the mammal an oral dosage form comprising a therapeutically effective amount of a first antioxidant, and (b) administering to the mammal a topical dosage form comprising a therapeutically effective amount of a second antioxidant, wherein at least one of the first antioxidant and the second antioxidant comprises acerola concentrate. Methods of inhibiting free radical production, methods of scavenging free radicals, and kits for reducing cellular damage are also described.
    Type: Application
    Filed: November 10, 2003
    Publication date: May 12, 2005
    Inventors: Gregory Evans, Gregory Grochoski, Keith Randolph, Lynne Connor, John Scimeca, Kevin Gellenbeck, James Mayne, Haeri Roh-Schmidt, Thomas Slaga, Margaret Hanausek-Walaszek, Zbigniew Walaszek